ABSTRACT. The purpose of this study was to identify genes and pathways for osteoarthritis (OA) diagnosis and therapy. We downloaded the gene expression profile of OA from Gene Expression Omnibus (GEO) database including 10 early OA, 9 late OA, and 5 normal control samples. Next, we screened differentially expressed genes (DEGs) between early-and late-stage OA samples comparing with healthy control samples. Then, the Search Tool for the Retrieval of Interacting Genes/Proteins (STRING) software was used to construct proteinprotein interaction (PPI) network, which was to predict the proteins that may interact with DEGs. The Gene Ontology (GO)-enrichment method was used to analyze the function of genes in the PPI networks. Meanwhile network module analysis was performed using Cytoscape. A total of 24 and 29 DEGs were identified for the early and late OA, respectively. TAC1 showed the highest degree in the PPI network. Functional annotation of the TAC1 network module indicated that this gene is associated with the G protein-coupled signal transduction pathway. In summary, TAC1, together with G protein-coupled receptors, appear to play a role in the biogenesis and progress of OA. Further analysis of this gene and pathway could therefore provide a potential target for the diagnosis and treatment of OA.
INTRODUCTION
Osteoarthritis (OA) is a well-known form of degenerative arthritis, degenerative joint disease, or osteoarthrosis, and leads to a series of mechanical abnormalities involving degradation of joints, including the articular cartilage and subchondral bone (Dorland, 1901, Goldring and Goldring, 2010) . OA likely begins to occur in humans in their 20s, although most cases are asymptomatic at this stage, and the disease is rarely identified (Holden et al., 1988) . The disease generally does not cause functional disability. Most symptoms are confined to be in the joint, and few patients experience oppression by the nerve root, resulting in corresponding physical nerve root pain or conduction paresthesia (NCCC, 2008) . Most nerve symptoms can be improved after rest or treatment, while some individuals experience paralysis of neurons (McPhee et al., 2010) . Rarely, patients may experience an oppressed vertebral artery (Chen et al., 2001) . Because diagnosis during the early stage is difficult, so the disease is more likely to cause harm to the patient.
Gene therapy has been proposed to be a strategy. Interleukin-1 is a promising therapy target, which mediates the cartilage loss in OA (Evans et al., 2004) . Gene expression profiling reveals that down-regulation of important oxidative defense genes such as glutathione peroxidase 3 and superoxide dismutases 2 and 3 were prominent (Aigner et al., 2006) . Another study also performed global gene expression in OA, which focus on early OA demonstrating that Reln, Phex, Ltbp2, Cxcr4, Ccl2 , and growth factor signaling pathway may be potential targets for OA therapy (Appleton et al., 2007) . Wang et al. (2011) demonstrated that complement played an important role in the pathogenesis of OA. However, the pathology of OA is not fully elucidated.
In this study, we analyzed early OA, late OA, and healthy subjects through a comparative analysis. The early, late OA samples, and healthy samples were obtained to identify gene expression differences and construct a network module, which may facilitate OA early detection and treatment.
MATERIAL AND METHODS

Dataset
We downloaded the gene dataset GSE32317 from the Gene Expression Omnibus (GEO; web site: http://www.ncbi.nlm.nih.gov/geo/) database. The gene expression profile contained 24 samples from 10 patients with early-stage knee OA who were PPI analysis of genes in osteoarthritis undergoing arthroscopic procedures for degenerative meniscal tears, 9 patients with late-stage knee OA who were undergoing total knee joint replacement, and 5 samples of healthy synovial membranes, which were run on the same platform and array as our OA samples. These data were downloaded from National Center for Biotechnology Information (NCBI) GEO database (accession No. GSE12021) and used for analysis.
Data preprocessing
The dataset was first used to fill in missing data using the K-nearest neighbors method in R language (Troyanskaya et al., 2001) , and then the data were normalized using the robust multi-array average (Fujita et al., 2006) algorithm. All expression values were then converted to fold-changes (FC) with log2 base. Probe sets were mapped to NCBI Entrez genes. If there were multiple probe sets corresponding to the same gene, the expression values of the probe sets were averaged. As a result, a total of 19,803 genes were identified from this dataset.
Screening differentially expressed genes (DEGs)
Three statistical test methods were used, including the Student t-test, the Wilcox test, and the Fisher exact test in the multi-test package in the R platform (Ihaka and Gentleman, 1996) , which was used to perform strict expression analysis of the data between the early and the late OA group comparing with the healthy group, respectively. P values were calculated using multiple testing correction, and the logFC of each gene expression value was investigated. Through multiple testing and screening methods, we identified abnormal genes in different stages of OA samples and significantly DEGs between the two OA stages (P < 0.05; logFC > 1). These genes were then used for further analysis.
Construction of protein-protein interaction (PPI) network
The Search Tool for the Retrieval of Interacting Genes/Proteins (STRING) (von Mering et al., 2007 ) is a database containing all known and predicted protein interactions. The interactions include direct (physical) and indirect (functional) associations derived from 4 sources, including genome, high-throughput experiments, co-expression, and prior knowledge. We employed STRING to identify pairwise relationships among the DEGs.
Module network analysis
Gene products in the same module often have the same or similar functions; they work together to carry out one biological function. Therefore, we used the Cytoscape software (Smoot et al., 2011) to perform module network analysis. We used Mcode plugin (Kohl et al., 2011) to create modules including 3 target genes (module division parameters: degree cutoff ≥ 2; score of each node in the module must be more than 0.2; neighbors of each node in the module must be more than 2; and the depth must be at least 100), and then another plugin of Cytoscape, Bingo (Maere et al., 2005) , was used to annotate module function.
RESULTS
Data preprocessing
For various reasons, such as background, probe design and so on, there were significant differences among original chip data. Therefore, data standardization is necessary before DEG analysis. MA plot is commonly used to observe the distribution of microarray data, which is the scattergram with M (log ratio expression) as the ordinate, and A (log average expression) as the abscissa. The MA plots of the standardized microarray gene expression data were presented as Figure 1 . Based on the distribution data, Lowess regression curve ( Figure  1 ) was plotted, which is a nonparametric regression method, and can be used to determine the relationship between 2 variables. The more smooth the regression curve, the better the normalization (Bolstad et al., 2003) . 
Screening of DEGs
Three statistical test methods (Student t-test, Wilcox rank, and Fisher accurate inspection test) were used to examine the gene expression data, which were then performed multiple correction using Benjamini and Hochberg method (Benjamini and Hochberg, 1995) . We identified probes with P values less than 0.05, and the absolute value of logFC was more than 1. Then the probes were mapped to gene names. Finally, 24 and 29 DEGs were identified for the early and late OA, respectively (Tables 1 and 2 , and Figure 2) . Tables 1 and 2 show that DEGs in the two OA groups have the same expression values compared to healthy controls. Figure  3 shows the cluster analysis of expression differences (logFC) between early-and late-stage osteoporosis samples comparing with healthy samples (Table 3) .
PPI network construction
We used the STRING database to predict interactions of 5 significantly DEGs with the proteins. Finally, 4228 possible interactions were obtained but only IGJ, TAC1, and LRP1B were predicted to be interacted with other proteins. Cytoscape was used to construct a PPI network diagram, which is shown as Figure 4 . Table 4 presents the degree of nodes IGJ, TAC1, and LRP1B; TAC1 had the highest node degree at 99. Therefore, the TAC1 gene was selected for further analysis. Table 3 . Expression level (logFC) of differentially expressed genes in early-and late-stage osteoarthritis.
Analysis of modules in the network
The interaction network can be divided into several relatively independent sub-networks, in which the protein typically has similar function. This type of close relationship is known as a function module. Identifying such modules is very important for understanding the biological system structure. Thus, the Cytoscape network analysis software was used for the module analysis of the network. Using the Mcode plugin, the module, which three target genes (IGJ, TAC1, and LRP1B) lied in, was identified. Figure 5 shows the network module which TAC1 lied in. Module function annotation by Bingo plugin showed that the module was mainly enriched in the G protein-coupled receptor protein signal transduction pathway. Table 4 . Degree of genes in the STRING-predicted protein-protein interaction network. 
DISCUSSION
OA is one of the most common chronic and progressive joint diseases, and is caused by an imbalance between the degradation and synthesis of cartilage cells, the extracellular matrix, and subchondral bone (Sandell and Aigner, 2001; Hayami et al., 2004) . Several risk factors, including biological factors and mechanical injury factors, may lead to OA.
By analyzing gene expression levels, we found that the TAC1 was significantly differentially expressed between different stages of OA (early and late). The module, which TAC1 lied in, was involved in the G protein-coupled receptor signal transduction pathway. We can, therefore, infer that the TAC1 is closely related to OA development. TAC1 encodes tachykinin NK2, a protein belonging to the tachykinin (TK) family, which includes substance P (SP), neurokinin A, and its elongated forms neuropeptide-gamma and neuropeptide-kappa, neurokinin B, hemokinin-1, and endokinin A and B, which belong to a family of peptides that act through the stimulation of tachykinin NK1, NK2, or NK3 receptors (Patacchini et al., 2004) . Recent studies have shown that TAC1 plays an important role in the estrous cycle and during pregnancy (Patak et al., 2005) . In addition, TKs and TK receptors are expressed throughout the male reproductive tract and have been reported to be involved in the regulation of human sperm motility (Ravina et al., 2007) . Interestingly, the reproductive system is related to bone formation, implying that TAC1 acts as a bridge between OA and the reproductive system (Clarke and Khosla, 2010).
Signal transduction of G protein-coupled receptors is a common target in drug discovery research. G protein-coupled receptors mainly regulate macrophage function and play a role in some OA pathology pathways and in biological functions (Lattin et al., 2007) . We found that TAC1 together with G protein-coupled receptors play a role in the biogenesis and progress of OA. Further analysis of this pathway could, therefore, provide a potential target for the treatment of OA.
Currently, the biogenesis and progress of OA syndrome can be examined at the genetic level by using microarray technology. The biological function of a gene can be predicted by the expression level of its encoded protein in cells, and the pathological process can be elucidated by examining changes in the gene expression profile between OA and normal cells. Therefore, in this study, information collected regarding the gene expression profile and the biogenesis and progress of OA may facilitate the development of treatment options for OA and various other diseases. Additional OA-related genes can also be identified through further examination of this network.
In conclusion, we analyzed the gene expression profiles of different stages of OA using bioinformatic analysis and found that the identified DEGs and several associated pathways, particularly the TAC1 and the G protein-coupled receptor pathway, may play important roles in the progression of the early and late stages of OA. These may become specific therapeutic molecular targets for OA treatment. However, further experiments are necessary to confirm our results.
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